Nrc Health (NRC) Liabilities and Shareholders Equity (2010 - 2026)

Nrc Health has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $134.6 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity changed 0.46% year-over-year to $134.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $546.5 million (up 5.39% YoY) and the FY2025 annual result came in at $134.9 million, up 1.76% from the prior year.
• Liabilities and Shareholders Equity steadied at $134.6 million in Q1 2026 per NRC's latest filing, from $134.9 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $153.2 million in Q1 2022 and troughed at $119.1 million in Q2 2024.
• A 5-year average of $132.4 million and a median of $134.3 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity decreased 17.19% in 2022, then increased 18.71% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $130.5 million in 2022, then retreated by 6.15% to $122.4 million in 2023, then rose by 8.25% to $132.5 million in 2024, then climbed by 1.76% to $134.9 million in 2025, then declined by 0.24% to $134.6 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $134.6 million, $134.9 million, and $135.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.